Open tender · Germany · Pharmaceutical products
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tolvaptan (ausschl. Wirkstärke 7,5mg in der Normgröße N2), f. d.Z. 01.7.26 - 30.6.28 (zzgl. V.-Option 1x12 M)
In EnglishConclusion of a non-exclusive discount agreement under § 130a para. 8 SGB V for the active ingredient Tolvaptan (excluding strength 7.5mg in standard size N2), for the period 01.07.26 - 30.06.28 (plus option for 1x12 months)
DAK-Gesundheit in Germany is inviting bids for “Conclusion of a non-exclusive discount agreement under § 130a para. 8 SGB V for the active ingredient Tolvaptan (excluding strength 7.5mg in standard…”. Bids close on 5 May 2029, 12:00 CEST. askTender lists every requirement to qualify and checks whether your company meets them.
The work
Abschluss einer nicht-exklusiven Rabattvereinbarung für den Wirkstoff Tolvaptan (7,5mg N2) für die DAK-Gesundheit.
Key facts
- Procedure
- Contract notice
Before you bid, askTender
Everything else is in your askTender account
askTender has broken this tender down into 0 requirements to qualify and the 5 documents a bidder must file.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences